Chymotrypsin inhibitory conformation of dipeptides constructed by side chain-side chain hydrophobic interactions. 1993

H Sakamoto, and Y Shimohigashi, and I Maeda, and T Nose, and K Nakashima, and I Nakamura, and T Ogawa, and K Kawano, and M Ohno
Department of Chemistry, Faculty of Science, Kyushu University, Fukuoka, Japan.

A complete series of configurational isomers (L-L, L-D, D-L and D-D) of a dipeptide Leu-Phe benzyl ester have been synthesized and assayed for chymotrypsin. In the conformational analysis by 400 MHz 1H NMR, the L-D and D-L isomers, but not the L-L and D-D isomers, showed fairly large upfield shifts (0.2-0.4 ppm) of Leu-beta CH2 and gamma CH proton signals, indicating the presence of shielding effects from the benzene ring. In addition to distinct signal splitting of Phe-beta CH2, the NOE enhancement observed between Leu-delta CH3 and Phe-phenyl groups revealed that these groups are in close proximity. These data indicated that L-D and D-L isomers form a hydrophobic core between side chains of adjacent Leu and Phe residues. When the dipeptides were examined for inhibition of chymotrypsin using Ac-Tyr-OEt as a substrate, the L-L isomer showed no inhibition, itself becoming a substrate. However, the other three isomers inhibited chymotrypsin in a competitive manner, and the D-L isomer was strongest with Ki of 2.2 x 10(-5) M. It was found that the D-L isomer was only slowly hydrolysed but the L(or D)-D isomer was not. H-D-Phe-L-Leu-OBzl with the inverse sequence of H-D-Leu-L-Phe-OBzl inhibited chymotrypsin more strongly (Ki = 6.3 x 10(-6) M).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002918 Chymotrypsin A serine endopeptidase secreted by the pancreas as its zymogen, CHYMOTRYPSINOGEN and carried in the pancreatic juice to the duodenum where it is activated by TRYPSIN. It selectively cleaves aromatic amino acids on the carboxyl side. Alpha-Chymotrypsin Choay,Alphacutanée,Avazyme
D004151 Dipeptides Peptides composed of two amino acid units. Dipeptide
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

H Sakamoto, and Y Shimohigashi, and I Maeda, and T Nose, and K Nakashima, and I Nakamura, and T Ogawa, and K Kawano, and M Ohno
January 1972, Biopolymers,
H Sakamoto, and Y Shimohigashi, and I Maeda, and T Nose, and K Nakashima, and I Nakamura, and T Ogawa, and K Kawano, and M Ohno
November 1967, Journal of the American Chemical Society,
H Sakamoto, and Y Shimohigashi, and I Maeda, and T Nose, and K Nakashima, and I Nakamura, and T Ogawa, and K Kawano, and M Ohno
February 1969, Journal of the American Chemical Society,
H Sakamoto, and Y Shimohigashi, and I Maeda, and T Nose, and K Nakashima, and I Nakamura, and T Ogawa, and K Kawano, and M Ohno
April 1996, Current opinion in structural biology,
H Sakamoto, and Y Shimohigashi, and I Maeda, and T Nose, and K Nakashima, and I Nakamura, and T Ogawa, and K Kawano, and M Ohno
February 1984, International journal of peptide and protein research,
H Sakamoto, and Y Shimohigashi, and I Maeda, and T Nose, and K Nakashima, and I Nakamura, and T Ogawa, and K Kawano, and M Ohno
December 1997, Protein science : a publication of the Protein Society,
H Sakamoto, and Y Shimohigashi, and I Maeda, and T Nose, and K Nakashima, and I Nakamura, and T Ogawa, and K Kawano, and M Ohno
December 2001, Chemistry (Weinheim an der Bergstrasse, Germany),
H Sakamoto, and Y Shimohigashi, and I Maeda, and T Nose, and K Nakashima, and I Nakamura, and T Ogawa, and K Kawano, and M Ohno
January 1991, Journal of molecular biology,
H Sakamoto, and Y Shimohigashi, and I Maeda, and T Nose, and K Nakashima, and I Nakamura, and T Ogawa, and K Kawano, and M Ohno
June 1969, Biopolymers,
H Sakamoto, and Y Shimohigashi, and I Maeda, and T Nose, and K Nakashima, and I Nakamura, and T Ogawa, and K Kawano, and M Ohno
January 1969, Biopolymers,
Copied contents to your clipboard!